Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Longeveron Inc
(NQ:
LGVN
)
1.160
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Longeveron Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Recap: Longeveron Q1 Earnings
May 12, 2023
Via
Benzinga
Preview: Longeveron's Earnings
May 11, 2023
Via
Benzinga
Longeveron's Lomecel-BTM Shows Encouraging Survival Data, Keeps Hypoplastic Left Heart Syndrome Pediatric Patients Heart Transplant-Free
May 09, 2023
Longeveron Inc (NASDAQ: LGVN) announced new long-term follow-up data from its ELPIS I trial of Lomecel-BTM for patients with
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 09, 2023
Via
Benzinga
Why Is Longeveron (LGVN) Stock Up 30% Today?
May 09, 2023
Longeveron (LGVN) stock is on the move Tuesday after releasing new long-term survival data from HLHS treatment Lomecel-B.
Via
InvestorPlace
Longeveron Doses First Patient In Phase 2 Clinical Trial Of Lomecel-B™ In Japan For Aging-Related Frailty
April 20, 2023
Longeveron Inc. (NASDAQ: LGVN) announced that the first patient has been treated with Lomecel-BTM in its Phase 2 clinical trial in patients with Aging-Related Frailty in Japan. The trial aims to enroll...
Via
Benzinga
Longeveron: Q2 Earnings Insights
August 12, 2022
Longeveron (NASDAQ:LGVN) reported its Q2 earnings results on Friday, August 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
Earnings Scheduled For March 10, 2023
March 10, 2023
Companies Reporting Before The Bell • CSI Compressco (NASDAQ:CCLP) is estimated to report earnings for its fourth quarter. • Longeveron (NASDAQ:LGVN) is expected to report earnings for its fourth...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
On Tuesday, 74 companies achieved new lows for the year.
Via
Benzinga
Insiders Just Bought $1 Million of This Deep Value Tech Stock
March 07, 2023
CEO and CFO buying is a bullish indicator... and based on new SEC filings, things are heating up for IHRT stock. Dive in here.
Via
InvestorPlace
3 Penny Stocks That Could Rise 500% in 2023
January 13, 2023
Tilt the odds in your favor in 2023 with some of these high-potential penny stocks. The risks are high, but so are the rewards.
Via
InvestorPlace
Longeveron Shares Surge Following FDA Decision on Biogen Alzheimer's Drug
January 06, 2023
Shares of Longeveron (NASDAQ: LGVN) are trading 5.37% higher amid strength in Alzheimer's-related stocks after the FDA granted accelerated approval to Biogen (NASDAQ: BIIB)'s Leqembi.
Via
Benzinga
Elon Musk Is a Genius Market Timer. That’s Bad News for Tesla (TSLA) Stock.
December 19, 2022
Elon Musk is great at timing the market. He's selling TSLA stock now, and savvy investors would be wise to follow suit.
Via
InvestorPlace
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Via
Benzinga
How to Find Stocks That Rise 10x
October 10, 2022
Investors looking for 10X stocks should prioritize companies in high-growth areas that demonstrate high earnings quality.
Via
InvestorPlace
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
September 29, 2022
Gainers
Via
Benzinga
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 28, 2022
Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 28, 2022
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
Via
InvestorPlace
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket
September 28, 2022
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.
Via
Benzinga
Longeveron's Return On Capital Employed Insights
September 09, 2022
Longeveron (NASDAQ:LGVN) brought in sales totaling $466 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 60.23%, resulting in a loss of $5.62 million.
Via
Benzinga
PFE, MRNA Stocks: What to Know as the FDA Approves New Booster Shots
August 31, 2022
Pfizer (PFE) and Moderna (MRNA) stocks are in the news Wednesday as the FDA approves new booster shots for the Covid-19 Omicron variant.
Via
InvestorPlace
Why Is Longeveron (LGVN) Stock on the Move Today?
August 31, 2022
Longeveron (LGVN) stock is on the move Wednesday after the FDA granted its fast-track designation for heart treatment Lomecel-B.
Via
InvestorPlace
Longeveron Shares Ascend As FDA Grants Fast Track Status To Congenital Heart Disease Candidate
August 31, 2022
Longeveron (NASDAQ: LGVN) received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its lead drug Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome (HLHS).
Via
Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Product Gets US FDA Fast Track Designation For Treatment Of Hypoplastic Left Heart Syndrome in Infants
August 31, 2022
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Longeveron Inc (NASDAQ: LGVN) Lomecel-B for the treatment of Hypoplastic Left Heart...
Via
Benzinga
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods To Monitor Efficacy Of Lomecel-B™ Cell Therapy
August 26, 2022
Longeveron Inc. (NASDAQ: LGVN) announced that the European Patent Office (EPO) had issued a notice of its intent to grant the Company a patent (EP Application No.
Via
Benzinga
EXCLUSIVE: Longeveron's Heart Disease Cell Therapy Poised To Secure European Patent
August 25, 2022
The European Patent Office has issued a notice of its intent to grant Longeveron Inc (NASDAQ: LGVN) a patent related to methods to treat endothelial dysfunction and monitor the efficacy of allogeneic...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 24, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.